Literature DB >> 11589719

Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters.

N Méndez-Sánchez1, E Roldán-Valadez, M A Flores, R Cárdenas-Vázquez, M Uribe.   

Abstract

BACKGROUND: We have evidence for enterohepatic cycling of bilirubin experimentally and in vivo in humans. This study was designed to investigate whether Zn salts might inhibit such cycling of bilirubin.
MATERIALS AND METHODS: Micellar bile salt solutions with unconjugated bilirubin were prepared, appropriate concentrations of Zn salts were added, and unconjugated bilirubin precipitation was measured. Hamsters and Wistar rats were fed a chow diet or a chow diet enriched with 1% ZnSO4, and bilirubin secretion rates were monitored.
RESULTS: Unconjugated bilirubin was precipitated maximally (90%) after a 10-min incubation with 5 mM Zn salts in the pH range of 6.8-9.0. In control hamsters, total bilirubin secretion rates into bile were 36.0 +/- 2.8 nmol h(-1) 100g(-1) body weight, whereas they were 25.0 +/- 3.3 nmol h-1 100(-1) g in the ZnSO4 group (P < 0.05).
CONCLUSIONS: Zn salts that flocculate at physiological pH adsorb unconjugated bilirubin almost completely from unsaturated micellar BS solutions. In addition, Zn salts administered orally suppress biliary bilirubin secretion rates in hamsters. These findings suggest that the administration of Zn salts may inhibit the enterohepatic cycling of unconjugated bilirubin in humans who are predisposed to pigment gallstone formation due to diet, disease or drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589719     DOI: 10.1046/j.1365-2362.2001.00879.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

Review 1.  Oral zinc for the prevention of hyperbilirubinaemia in neonates.

Authors:  Satish Mishra; Aminderjit Cheema; Ramesh Agarwal; Ashok Deorari; Vinod Paul
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

2.  Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial.

Authors:  Nidhi Rana; Satish Mishra; Shinjini Bhatnagar; Vinod Paul; Ashok Kumar Deorari; Ramesh Agarwal
Journal:  Indian J Pediatr       Date:  2011-04-01       Impact factor: 1.967

3.  Evaluation of Serum Zinc Levels in Hyperbilirubinemic Neonates Before and After Phototherapy.

Authors:  Ziba Mosayebi; Maral Rahmani; Shahin Behjati Ardakani; Mahdi Sheikh; Mamak Shariat; Golnaz Rezaeizadeh
Journal:  Iran J Pediatr       Date:  2016-03-17       Impact factor: 0.364

4.  Efficacy of zinc sulfate on indirect hyperbilirubinemia in premature infants admitted to neonatal intensive care unit: a double-blind, randomized clinical trial.

Authors:  Gholamreza Faal; Hoda Khatib Masjedi; Gholamreza Sharifzadeh; Zahra Kiani
Journal:  BMC Pediatr       Date:  2020-03-19       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.